{
  "trial_id": "NCT01545336",
  "trial_group": "hypertension",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, sex, mean pulmonary artery pressure, pulmonary capillary wedge pressure, pulmonary vascular resistance (PVR), forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), total lung capacity, six-minute walk distance, follicle-stimulating hormone (FSH) levels, history of hormone therapy, WHO functional class, history of breast cancer, sleep apnea status, left-sided valvular disease status, ejection fraction, PAH therapy status, renal function (creatinine levels), Child-Pugh class, alcohol consumption history, use of investigational drugs, enrollment in other clinical trials.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Six minute walk distance",
          "six-minute walk distance"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "mean pulmonary artery pressure",
        "pulmonary capillary wedge pressure",
        "pulmonary vascular resistance (PVR)",
        "forced expiratory volume in 1 second (FEV1)",
        "forced vital capacity (FVC)",
        "total lung capacity",
        "follicle-stimulating hormone (FSH) levels",
        "history of hormone therapy",
        "WHO functional class",
        "history of breast cancer",
        "sleep apnea status",
        "left-sided valvular disease status",
        "ejection fraction",
        "PAH therapy status",
        "renal function (creatinine levels)",
        "Child-Pugh class",
        "alcohol consumption history",
        "use of investigational drugs",
        "enrollment in other clinical trials."
      ]
    },
    "processed-gen-response": "Age, sex, mean pulmonary artery pressure, pulmonary capillary wedge pressure, pulmonary vascular resistance (PVR), forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), total lung capacity, six-minute walk distance, follicle-stimulating hormone (FSH) levels, history of hormone therapy, WHO functional class, history of breast cancer, sleep apnea status, left-sided valvular disease status, ejection fraction, PAH therapy status, renal function (creatinine levels), Child-Pugh class, alcohol consumption history, use of investigational drugs, enrollment in other clinical trials."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Mean Pulmonary Artery Pressure, Pulmonary Vascular Resistance, Pulmonary Capillary Wedge Pressure, Forced Expiratory Volume in 1 Second (FEV1), Forced Vital Capacity (FVC), Total Lung Capacity, Six Minute Walk Distance, Functional Class, Creatinine, ",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Six minute walk distance",
          "Six Minute Walk Distance"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Mean Pulmonary Artery Pressure",
        "Pulmonary Vascular Resistance",
        "Pulmonary Capillary Wedge Pressure",
        "Forced Expiratory Volume in 1 Second (FEV1)",
        "Forced Vital Capacity (FVC)",
        "Total Lung Capacity",
        "Functional Class",
        "Creatinine"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Mean Pulmonary Artery Pressure, Pulmonary Vascular Resistance, Pulmonary Capillary Wedge Pressure, Forced Expiratory Volume in 1 Second (FEV1), Forced Vital Capacity (FVC), Total Lung Capacity, Six Minute Walk Distance, Functional Class, Creatinine"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, Pulmonary Arterial Hypertension (PAH) diagnosis duration, WHO functional class, Six-minute walk distance, Right ventricular function, Pulmonary vascular resistance, Forced Expiratory Volume in 1 second (FEV1), Forced Vital Capacity (FVC), Total lung capacity, Follicle-stimulating hormone (FSH) levels.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Six minute walk distance",
          "Six-minute walk distance"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Body Mass Index",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Pulmonary Arterial Hypertension (PAH) diagnosis duration",
        "WHO functional class",
        "Right ventricular function",
        "Pulmonary vascular resistance",
        "Forced Expiratory Volume in 1 second (FEV1)",
        "Forced Vital Capacity (FVC)",
        "Total lung capacity",
        "Follicle-stimulating hormone (FSH) levels."
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, Pulmonary Arterial Hypertension (PAH) diagnosis duration, WHO functional class, Six-minute walk distance, Right ventricular function, Pulmonary vascular resistance, Forced Expiratory Volume in 1 second (FEV1), Forced Vital Capacity (FVC), Total lung capacity, Follicle-stimulating hormone (FSH) levels."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), mean pulmonary artery pressure, pulmonary capillary wedge pressure, pulmonary vascular resistance (PVR), forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), total lung capacity, six-minute walk distance, World Health Organization (WHO) functional class, PAH etiology, duration of PAH diagnosis, current PAH therapy, follicle-stimulating hormone (FSH) levels, creatinine levels, ejection fraction, tricuspid annular plane systolic excursion (TAPSE) at baseline.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "Six minute walk distance",
          "six-minute walk distance"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "body mass index (BMI)",
        "mean pulmonary artery pressure",
        "pulmonary capillary wedge pressure",
        "pulmonary vascular resistance (PVR)",
        "forced expiratory volume in 1 second (FEV1)",
        "forced vital capacity (FVC)",
        "total lung capacity",
        "World Health Organization (WHO) functional class",
        "PAH etiology",
        "duration of PAH diagnosis",
        "current PAH therapy",
        "follicle-stimulating hormone (FSH) levels",
        "creatinine levels",
        "ejection fraction",
        "tricuspid annular plane systolic excursion (TAPSE) at baseline"
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, body mass index (BMI), mean pulmonary artery pressure, pulmonary capillary wedge pressure, pulmonary vascular resistance (PVR), forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), total lung capacity, six-minute walk distance, World Health Organization (WHO) functional class, PAH etiology, duration of PAH diagnosis, current PAH therapy, follicle-stimulating hormone (FSH) levels, creatinine levels, ejection fraction, tricuspid annular plane systolic excursion (TAPSE) at baseline."
  }
}